Streetbeat News

Price Targets

KRON

HC Wainwright & Co. analyst Robert Burns maintains a 'Buy' rating on Kronos Bio (NASDAQ:KRON) but has lowered the price target from $10 to $9.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 10:37 am

KA

HC Wainwright & Co. analyst Robert Burns has reiterated a 'Buy' rating on Kineta (NASDAQ:KA) and maintained an $8 price target.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 10:35 am

A

HD

NVDA

OXY

TRMR

Five of Wall Street's most accurate analysts have made new stock picks. Leo Mariani from Roth MKM reiterated a Neutral rating on Occidental Petroleum Corporation (OXY) with a price target of $60, seeing a 6% downside. Zachary Fadem from Wells Fargo maintained an Overweight rating on The Home Depot, Inc. (HD) and raised the price target to $360, predicting a 10% upside. Mark Kelley from Stifel maintained a Hold rating on Tremor International Ltd (TRMR) and cut the price target to $4.5, seeing a 10% upside. Chris Caso from Raymond James maintained a Strong Buy rating on NVIDIA Corporation (NVDA) and raised the price target to $500, predicting over a 15% upside. Brandon Couillard from Jefferies maintained a Buy rating on Agilent Technologies, Inc. (A) and cut the price target to $146, predicting a 22% upside.

Portfolio Pulse from Lisa Levin

August 21, 2023 | 10:35 am

NBIX

HC Wainwright & Co. analyst Andrew Fein maintains a 'Buy' rating on Neurocrine Biosciences (NASDAQ:NBIX) and raises the price target from $140 to $146.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 10:34 am

BNS

Barclays analyst John Aiken has maintained an Underweight rating on Bank of Nova Scotia (NYSE:BNS) and raised the price target from C$63 to C$65.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 10:34 am

NMRD

HC Wainwright & Co. analyst Yi Chen maintains a 'Buy' rating on Nemaura Medical (NASDAQ:NMRD) but lowers the price target from $7 to $2.5.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 10:33 am

BMO

Barclays analyst John Aiken has maintained an Overweight rating on Bank of Montreal (NYSE:BMO) and raised the price target from $123 to $131.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 10:31 am

NUVB

HC Wainwright & Co. analyst Robert Burns has reiterated a 'Buy' rating on Nuvation Bio (NYSE:NUVB) and maintained a price target of $4.5.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 10:31 am

NSSC

Needham analyst James Ricchiuti has maintained a 'Buy' rating on NAPCO Security Techs (NASDAQ:NSSC), but lowered the price target from $39 to $30.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 10:30 am

ELBM

HC Wainwright & Co. analyst Heiko Ihle maintains a 'Buy' rating on Electra Battery Materials (NASDAQ:ELBM), but has lowered the price target from $4.5 to $2.5.

Portfolio Pulse from richadhand@benzinga.com

August 21, 2023 | 10:29 am